"interleukin-35, mouse"[nm] - Search Results

Year	Number of Results
2011	2
2012	5
2013	4
2014	14
2015	10
2016	11
2017	13
2018	13
2019	18
2020	17
2021	8
2022	4
2023	1
2024	1

1

STING-induced regulatory B cells compromise NK function in cancer immunity.

Li S, Mirlekar B, Johnson BM, Brickey WJ, Wrobel JA, Yang N, Song D, Entwistle S, Tan X, Deng M, Cui Y, Li W, Vincent BG, Gale M Jr, Pylayeva-Gupta Y, Ting JP. Li S, et al. Nature. 2022 Oct;610(7931):373-380. doi: 10.1038/s41586-022-05254-3. Epub 2022 Oct 5. Nature. 2022. PMID: 36198789 Free PMC article.

2

Interleukin-35 induces regulatory B cells that suppress autoimmune disease.

Wang RX, Yu CR, Dambuza IM, Mahdi RM, Dolinska MB, Sergeev YV, Wingfield PT, Kim SH, Egwuagu CE. Wang RX, et al. Nat Med. 2014 Jun;20(6):633-41. doi: 10.1038/nm.3554. Epub 2014 Apr 17. Nat Med. 2014. PMID: 24743305 Free PMC article.

3

Interleukin-35 Limits Anti-Tumor Immunity.

Turnis ME, Sawant DV, Szymczak-Workman AL, Andrews LP, Delgoffe GM, Yano H, Beres AJ, Vogel P, Workman CJ, Vignali DA. Turnis ME, et al. Immunity. 2016 Feb 16;44(2):316-29. doi: 10.1016/j.immuni.2016.01.013. Epub 2016 Feb 9. Immunity. 2016. PMID: 26872697 Free PMC article.

4

Interleukin-35 Promotes Macrophage Survival and Improves Wound Healing After Myocardial Infarction in Mice.

Jia D, Jiang H, Weng X, Wu J, Bai P, Yang W, Wang Z, Hu K, Sun A, Ge J. Jia D, et al. Circ Res. 2019 Apr 26;124(9):1323-1336. doi: 10.1161/CIRCRESAHA.118.314569. Circ Res. 2019. PMID: 30832557

5

Interleukin 35 protects cardiomyocytes following ischemia/reperfusion-induced apoptosis via activation of mitochondrial STAT3.

Zhou F, Feng T, Lu X, Wang H, Chen Y, Zhang Q, Zhang X, Xiu J. Zhou F, et al. Acta Biochim Biophys Sin (Shanghai). 2021 Mar 26;53(4):410-418. doi: 10.1093/abbs/gmab007. Acta Biochim Biophys Sin (Shanghai). 2021. PMID: 33619515 Free article.

6

IL-35 and RANKL Synergistically Induce Osteoclastogenesis in RAW264 Mouse Monocytic Cells.

Kamiya Y, Kikuchi T, Goto H, Okabe I, Takayanagi Y, Suzuki Y, Sawada N, Okabe T, Suzuki Y, Kondo S, Hayashi JI, Mitani A. Kamiya Y, et al. Int J Mol Sci. 2020 Mar 18;21(6):2069. doi: 10.3390/ijms21062069. Int J Mol Sci. 2020. PMID: 32197293 Free PMC article.

7

Interleukin-35 (IL-35) inhibits proliferation and promotes apoptosis of fibroblast-like synoviocytes isolated from mice with collagen-induced arthritis.

Li Y, Wu S, Li Y, Jiang S, Lin T, Xia L, Shen H, Lu J. Li Y, et al. Mol Biol Rep. 2016 Sep;43(9):947-56. doi: 10.1007/s11033-016-4034-7. Epub 2016 Jul 5. Mol Biol Rep. 2016. PMID: 27379996

8

IL-35, a double-edged sword in cancer.

Yazdani Z, Rafiei A, Golpour M, Zafari P, Moonesi M, Ghaffari S. Yazdani Z, et al. J Cell Biochem. 2020 Mar;121(3):2064-2076. doi: 10.1002/jcb.29441. Epub 2019 Oct 21. J Cell Biochem. 2020. PMID: 31633232 Review.

9

Interleukin-35 Is Involved in Angiogenesis/Bone Remodeling Coupling Through T Helper 17/Interleukin-17 Axis.

Zhang H, Li Y, Yuan L, Yao L, Yang J, Xia L, Shen H, Lu J. Zhang H, et al. Front Endocrinol (Lausanne). 2021 Apr 16;12:642676. doi: 10.3389/fendo.2021.642676. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 33935967 Free PMC article.

10

Interleukin-35 pretreatment attenuates lipopolysaccharide-induced heart injury by inhibition of inflammation, apoptosis and fibrotic reactions.

Hu H, Fu Y, Li M, Xia H, Liu Y, Sun X, Hu Y, Song F, Cheng X, Li P, Wu Y. Hu H, et al. Int Immunopharmacol. 2020 Sep;86:106725. doi: 10.1016/j.intimp.2020.106725. Epub 2020 Jul 14. Int Immunopharmacol. 2020. PMID: 32679538

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Results by year